Nutritional Control of Cancer Cell Function by Amino Acids
Nutritional Control of Cancer Cell Function by Amino Acids
批准号:
9753749
负责人:
MICHAEL S. KILBERG
金额:
$33.28万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-08-01 至 2021-07-31
关键词:
Amino AcidsApoptosisAutophagocytosisBindingBinding ProteinsCCAAT-Enhancer-Binding ProteinsCancer ControlCancer and NutritionCancerousCell NucleusCell ProliferationCell physiologyCellsChemicalsCultured CellsDNA BindingDeletion MutagenesisDevelopmentDietDietary ProteinsDiseaseELK1 geneETS Family ProteinElementsEnhancersEssential Amino AcidsExhibitsExonucleaseFamilyGenesGenetic Enhancer ElementGenetic TranscriptionGenomicsGlioblastomaGoalsGrowthHealthHepG2HepatocyteHistidineHumanKnock-outKnowledgeLinkLiver neoplasmsMAP Kinase GeneMEKsMaintenanceMalignant Epithelial CellMalignant NeoplasmsMammalian CellMammalsMediatingModelingMusNeonatalNude MiceNutrientNutritionalOperative Surgical ProceduresPathologyPathway interactionsPhosphorylationPhosphotransferasesPost-Translational Protein ProcessingPrimary carcinoma of the liver cellsProliferatingProtein/Amino Acids NutritionProteinsRNA, Transfer, Amino Acid-SpecificRas/RafRecoveryRegulationResearchResponse ElementsSignal PathwaySignal TransductionSiteTestingTissuesTransfer RNATranslationsWorkactivating transcription factorarmc-myc Genescancer cellelk-1 proteinexperimental studyfetalgene inductiongenome-wideinnovationjun Oncogeneknock-downneoplastic cellnovelpublic health relevanceresponsesensorsmall hairpin RNAtranscription factortranscriptome sequencingtumortumor growthtumor xenograft
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Protein or amino acid (AA) limitation activates an AA response (AAR) comprised of several partially characterized signaling pathways. The best studied of these involves AA sensing by GCN2 kinase and culminates in ATF4-dependent transcription via genomic C/EBP-ATF response element (CARE) enhancer sites that exhibit AAR element (AARE) function. Using HepG2 human hepatocellular carcinoma (HCC) and U87 human glioblastoma cells as models, our recent research indicates that there are GCN2/ATF4-independent pathways that exhibit little or no contribution in non-transformed cells. One of these pathways is mediated through the RAS/RAF/MEK/ERK arm of MAPK signaling and terminates with ELK1 transcription factor binding to ETS enhancer sequences not previously known to exhibit AARE function. We have discovered that the ERK pathway makes a significant contribution to the regulation of hundreds of AA-responsive genes in human HCC cells, but not in normal hepatocytes. These novel observations underscore the significant gaps in our knowledge about the impact of AA availability on basic cell functions. Our global hypothesis is that in some tumor cells the mammalian AAR extends beyond GCN2/ATF4 and that AA signaling via MAPK pathways is a significant component of the AAR, which permits tumor cells to proliferate despite AA limitation. The proposed experiments will test the following specific hypotheses in cultured cells and tumor-bearing mice. (Hypothesis I) An ERK pathway contributes to novel AA signaling independent of GCN2-ATF4. (Hypothesis II) The ERK AAR pathway includes transcription factors not previously known to be AA-responsive and terminates in novel genomic sequences that have functional AARE activity. (Hypothesis III) Induction of ERK-dependent signaling contributes to continued tumor growth despite AA limitation. The proposed studies are conceptually innovative for the following reasons. 1) The current dogma that the GCN2-ATF4 pathway induces most/all AA- responsive genes must be expanded to include an unknown AA sensor, MAPK signaling, and enhancer sequences previously unknown to have AARE activity. 2) AA-dependent transcription via ELK1 reveals an entirely new family of transcription factors, the ETS family, within the AAR. 3) The ERK-driven induction of genes, such as EGR1, FOS, JUN, and MYC, in AA-deprived tumor cells suggests a link between protein/AA nutrition and tumor proliferation.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.bbagrm.2018.01.002
发表时间:
2018-03
期刊:
Biochimica et biophysica acta. Gene regulatory mechanisms
影响因子:
--
作者:
[Hayner JN, Shan J, Kilberg MS]
通讯作者:
Kilberg MS
DOI:
10.1016/j.tem.2017.07.003
发表时间:
2017-11
期刊:
Trends in endocrinology and metabolism: TEM
影响因子:
--
作者:
[Wortel IMN, van der Meer LT, Kilberg MS, van Leeuwen FN]
通讯作者:
van Leeuwen FN
DOI:
10.3390/cancers12113267
发表时间:
2020-11-05
期刊:
Cancers
影响因子:
5.2
作者:
[Chiu M, Toscani D, Marchica V, Taurino G, Costa F, Bianchi MG, Andreoli R, Franceschi V, Storti P, Burroughs-Garcia J, Eufemiese RA, Dalla Palma B, Campanini N, Martella E, Mancini C, Shan J, Kilberg MS, D'Amico G, Dander E, Agnelli L, Pruneri G, Donofrio G, Bussolati O, Giuliani N]
通讯作者:
Giuliani N
Induction of early growth response gene 1 (EGR1) by endoplasmic reticulum stress is mediated by the extracellular regulated kinase (ERK) arm of the MAPK pathways.
内质网应激对早期生长反应基因 1 (EGR1) 的诱导是由 MAPK 通路的细胞外调节激酶 (ERK) 臂介导的。
DOI:
10.1016/j.bbamcr.2018.09.009
发表时间:
2019
期刊:
Biochimica et biophysica acta. Molecular cell research
影响因子:
--
作者:
[Shan,Jixiu, Dudenhausen,Elizabeth, Kilberg,MichaelS]
通讯作者:
Kilberg,MichaelS
Amino Acid Regulation of the Fos/Jun Transcription Factors
-
批准号:8335468
-
项目类别:
-
资助金额:$31.43万
-
财政年份:2011
-
负责人:MICHAEL S. KILBERG
-
依托单位:
Amino Acid Regulation of Alternative Splicing
-
批准号:8705504
-
项目类别:
-
资助金额:$31.58万
-
财政年份:2011
-
负责人:MICHAEL S. KILBERG
-
依托单位:
Amino Acid Regulation of Alternative Splicing
-
批准号:8306037
-
项目类别:
-
资助金额:$31.65万
-
财政年份:2011
-
负责人:MICHAEL S. KILBERG
-
依托单位:
Amino Acid Regulation of Alternative Splicing
-
批准号:8204302
-
项目类别:
-
资助金额:$36.41万
-
财政年份:2011
-
负责人:MICHAEL S. KILBERG
-
依托单位:
Amino Acid Regulation of the Fos/Jun Transcription Factors
-
批准号:8257238
-
项目类别:
-
资助金额:$31.49万
-
财政年份:2011
-
负责人:MICHAEL S. KILBERG
-
依托单位:
Amino Acid Regulation of the Fos/Jun Transcription Factors
-
批准号:8535750
-
项目类别:
-
资助金额:$30.27万
-
财政年份:2011
-
负责人:MICHAEL S. KILBERG
-
依托单位:
Amino Acid Regulation of Alternative Splicing
-
批准号:8520000
-
项目类别:
-
资助金额:$30.51万
-
财政年份:2011
-
负责人:MICHAEL S. KILBERG
-
依托单位:
Amino Acid Regulation of the Fos/Jun Transcription Factors
-
批准号:8721948
-
项目类别:
-
资助金额:$31.29万
-
财政年份:2011
-
负责人:MICHAEL S. KILBERG
-
依托单位:
Nutritional Control of Transcription Factor Expression
-
批准号:7047133
-
项目类别:
-
资助金额:$28.91万
-
财政年份:2006
-
负责人:MICHAEL S. KILBERG
-
依托单位:
Nutritional Control of Transcription Factor Expression
-
批准号:7567479
-
项目类别:
-
资助金额:$27.41万
-
财政年份:2006
-
负责人:MICHAEL S. KILBERG
-
依托单位:
Nutritional Control of Transcription Factor Expression
-
批准号:7185757
-
项目类别:
-
资助金额:$28.04万
-
财政年份:2006
-
负责人:MICHAEL S. KILBERG
-
依托单位:
Nutritional Control of Transcription Factor Expression
-
批准号:7367127
-
项目类别:
-
资助金额:$27.45万
-
财政年份:2006
-
负责人:MICHAEL S. KILBERG
-
依托单位:
Nutritional Regulation of Ribosomal Protein Expression
-
批准号:6736276
-
项目类别:
-
资助金额:$24.0万
-
财政年份:2001
-
负责人:MICHAEL S. KILBERG
-
依托单位:
Nutritional Regulation of Ribosomal Protein Expression
-
批准号:6635350
-
项目类别:
-
资助金额:$23.94万
-
财政年份:2001
-
负责人:MICHAEL S. KILBERG
-
依托单位:
Nutritional Regulation of Ribosomal Protein Expression
-
批准号:6874301
-
项目类别:
-
资助金额:$23.99万
-
财政年份:2001
-
负责人:MICHAEL S. KILBERG
-
依托单位:
Nutritional Regulation of Ribosomal Protein Expression
-
批准号:6517873
-
项目类别:
-
资助金额:$23.96万
-
财政年份:2001
-
负责人:MICHAEL S. KILBERG
-
依托单位:
Nutritional Regulation of Ribosomal Protein Expression
-
批准号:6317171
-
项目类别:
-
资助金额:$23.96万
-
财政年份:2001
-
负责人:MICHAEL S. KILBERG
-
依托单位:
NUTRITIONAL CONTROL OF ASPARAGINE SYNTHETASE
-
批准号:2017608
-
项目类别:
-
资助金额:$19.29万
-
财政年份:1997
-
负责人:MICHAEL S. KILBERG
-
依托单位:
NUTRITIONAL CONTROL OF ASPARAGINE SYNTHETASE
-
批准号:6258555
-
项目类别:
-
资助金额:$30.89万
-
财政年份:1997
-
负责人:MICHAEL S. KILBERG
-
依托单位:
Nutritional Control of Asparagine Synthetase
-
批准号:6984016
-
项目类别:
-
资助金额:$32.26万
-
财政年份:1997
-
负责人:MICHAEL S. KILBERG
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: